Shun He

4.1k total citations
25 papers, 1.5k citations indexed

About

Shun He is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shun He has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Immunology. Recurrent topics in Shun He's work include Immune Cell Function and Interaction (8 papers), RNA Interference and Gene Delivery (7 papers) and CAR-T cell therapy research (5 papers). Shun He is often cited by papers focused on Immune Cell Function and Interaction (8 papers), RNA Interference and Gene Delivery (7 papers) and CAR-T cell therapy research (5 papers). Shun He collaborates with scholars based in United States, China and Japan. Shun He's co-authors include Jianhua Yu, Michael A. Caligiuri, Xiaoming He, Yong Peng, Tiffany Hughes, Youcai Deng, Craig C. Hofmeister, Kalpana Ghoshal, Steven M. Devine and Ling Yi and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Medicine and Nature Communications.

In The Last Decade

Shun He

24 papers receiving 1.5k citations

Peers

Shun He
Indira Neeli United States
P. J. Quesenberry United States
Juliane Lokau Germany
Ryan L. Kelly United States
Maria De Pizzol Italy
Kathy Barrett United Kingdom
Teresina Laragione United States
Panagiotis Karagiannis United Kingdom
Olaf R.F. Mook Netherlands
Xiaodong Zhu China
Indira Neeli United States
Shun He
Citations per year, relative to Shun He Shun He (= 1×) peers Indira Neeli

Countries citing papers authored by Shun He

Since Specialization
Citations

This map shows the geographic impact of Shun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun He more than expected).

Fields of papers citing papers by Shun He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun He. The network helps show where Shun He may publish in the future.

Co-authorship network of co-authors of Shun He

This figure shows the co-authorship network connecting the top 25 collaborators of Shun He. A scholar is included among the top collaborators of Shun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun He. Shun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Lu, et al.. (2026). Phospholipids tailor mRNA lipid nanoparticle delivery efficacy and immunogenicity. Materials Today. 92. 490–498.
2.
He, Shun & Shuai Liu. (2025). Research progress on lipid nanoparticle messenger RNA delivery system. Journal of Zhejiang University (Medical Sciences). 54(4). 446–454. 1 indexed citations
3.
Hu, Chao, Yu Chang, Jiaqing Li, et al.. (2025). Nanoparticles co-delivering double-stranded RNA and insecticide enhance control efficacy and overcome pest resistance. Chemical Engineering Journal. 519. 165188–165188. 1 indexed citations
4.
Zhang, Xinyue, Kexin Su, Lixin Lin, et al.. (2024). One‐Component Cationic Lipids for Systemic mRNA Delivery to Splenic T Cells. Angewandte Chemie. 136(26). 12 indexed citations
5.
He, Shun & Shuai Liu. (2023). Zwitterionic materials for nucleic acid delivery and therapeutic applications. Journal of Controlled Release. 365. 919–935. 22 indexed citations
6.
Vorst, Emiel P. C. van der, Shun He, Mathias Burgmaier, et al.. (2022). Gut immune cells—A novel therapeutical target for cardiovascular disease?. Frontiers in Cardiovascular Medicine. 9. 943214–943214. 3 indexed citations
7.
Anzai, Atsushi, John E. Mindur, Lennard Halle, et al.. (2019). Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis. The Journal of Experimental Medicine. 216(2). 369–383. 38 indexed citations
8.
Anzai, Atsushi, Jennifer L. Choi, Shun He, et al.. (2017). The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes. The Journal of Experimental Medicine. 214(11). 3293–3310. 168 indexed citations
9.
Teng, Kun‐Yu, Jianfeng Han, Xiaoli Zhang, et al.. (2016). Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. Molecular Cancer Therapeutics. 16(2). 312–322. 103 indexed citations
10.
Aryal, Binod, Noemí Rotllán, Elisa Araldi, et al.. (2016). ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nature Communications. 7(1). 12313–12313. 79 indexed citations
11.
He, Shun, Mei Liu, Weina Zhang, Ningzhi Xu, & Hongxia Zhu. (2016). Over expression of p21-activated kinase 7 associates with lymph node metastasis in esophageal squamous cell cancers. Cancer Biomarkers. 16(2). 203–209. 4 indexed citations
12.
Yoo, Ji Young, Brian Hurwitz, Chelsea Bolyard, et al.. (2014). Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects. Clinical Cancer Research. 20(14). 3787–3798. 64 indexed citations
13.
Chu, Jianhong, Shun He, Youcai Deng, et al.. (2014). Genetic Modification of T Cells Redirected toward CS1 Enhances Eradication of Myeloma Cells. Clinical Cancer Research. 20(15). 3989–4000. 92 indexed citations
14.
He, Shun, Jianhong Chu, Lai‐Chu Wu, et al.. (2013). MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood. 121(23). 4663–4671. 68 indexed citations
15.
Yu, Jianhua, Yong Peng, Lai‐Chu Wu, et al.. (2013). Curcumin Down-Regulates DNA Methyltransferase 1 and Plays an Anti-Leukemic Role in Acute Myeloid Leukemia. PLoS ONE. 8(2). e55934–e55934. 131 indexed citations
16.
He, Shun, Jianhong Chu, Sumithira Vasu, et al.. (2013). FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome. Biology of Blood and Marrow Transplantation. 20(3). 309–313. 15 indexed citations
17.
Chu, Jianjun, Youcai Deng, D.M. Benson, et al.. (2013). CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma. Leukemia. 28(4). 917–927. 373 indexed citations
18.
Chu, Jianhong, Youcai Deng, Don M. Benson, et al.. (2013). CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells and T Cells Enhance In Vitro and In Vivo Anti-Tumor Activity Against Human Multiple Myeloma. Blood. 122(21). 14–14. 2 indexed citations
19.
Alvarez‐Breckenridge, Christopher, Jianhua Yu, Richard L. Price, et al.. (2012). NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nature Medicine. 18(12). 1827–1834. 167 indexed citations
20.
Zhu, Hongxia, Guo Zhang, Yan Wang, et al.. (2010). Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2–β‐catenin/TCF4‐survivin pathway in ErbB2‐overexpressed breast cancer cells. Cancer Science. 101(5). 1156–1162. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Indira Neeli Breakdown of academic impact, for papers by P. J. Quesenberry Breakdown of academic impact, for papers by Juliane Lokau Breakdown of academic impact, for papers by Ryan L. Kelly Breakdown of academic impact, for papers by Maria De Pizzol Breakdown of academic impact, for papers by Kathy Barrett Breakdown of academic impact, for papers by Teresina Laragione Breakdown of academic impact, for papers by Panagiotis Karagiannis Breakdown of academic impact, for papers by Olaf R.F. Mook Breakdown of academic impact, for papers by Xiaodong Zhu
Rankless by CCL
2026